ANDA 90598, held by Strides Pharma Intl. Isosorbide Mononitrate.
As of Nov 16, 2026, ANDA 90598 (Isosorbide Mononitrate), held by Strides Pharma Intl, was first approved by FDA on Aug 11, 2010, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 11, 2010 | Original application | Approved | None posted |
| Isosorbide Mononitrate30MG · tablet, extended release;oral | Isosorbide Mononitrate | Discontinued |
| Isosorbide Mononitrate60MG · tablet, extended release;oral | Isosorbide Mononitrate | Discontinued |
| Isosorbide Mononitrate120MG · tablet, extended release;oral | Isosorbide Mononitrate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters